TALQUETAMAB-TGVS

TALQUETAMAB-TGVS was reported 1489 times

TALQUETAMAB-TGVS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANNIVERSARY REACTION 1 1.0000
1 ORAL TOXICITY 11 0.1964
2 BONE MARROW HARVEST 1 0.1667
3 MASKED FEVER 1 0.0714
4 SALIVARY HYPOSECRETION 10 0.0617
5 ANHIDROSIS 19 0.0466
6 NAIL DEFORMATION 3 0.0448
7 NAIL TOXICITY 11 0.0367
8 SAPOVIRUS INFECTION 1 0.0312
9 KERATOLYSIS EXFOLIATIVA ACQUIRED 1 0.0312
10 NAIL ATROPHY 1 0.0303
11 LYMPHODEPLETION 1 0.0294
12 BLOOD IMMUNOGLOBULIN A ABNORMAL 1 0.0263
13 HUMAN HERPESVIRUS 6 VIRAEMIA 1 0.0250
14 ONYCHOMALACIA 3 0.0240
15 TONGUE ROUGH 2 0.0235
16 ONYCHOMADESIS 87 0.0207
17 NAIL DYSTROPHY 11 0.0196
18 HAEMOPHILUS SEPSIS 1 0.0175
19 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 102 0.0172
20 ACUTE ERYTHROID LEUKAEMIA 1 0.0159
21 LEUKONYCHIA 1 0.0159
22 DENGUE HAEMORRHAGIC FEVER 1 0.0156
23 CYTOKINE RELEASE SYNDROME 296 0.0147
24 LIGHT CHAIN ANALYSIS DECREASED 1 0.0145
25 NAIL DISORDER 95 0.0108
26 MONOCLONAL IMMUNOGLOBULIN INCREASED 3 0.0105
27 HYPERCHROMIC ANAEMIA 1 0.0091
28 ONYCHALGIA 9 0.0090
29 ONYCHOLYSIS 14 0.0090
30 NAIL DISCOMFORT 1 0.0083
31 WRONG DOSAGE FORMULATION 1 0.0081
32 NEISSERIA INFECTION 1 0.0079
33 RETROPERITONEAL MASS 1 0.0072
34 NAIL DISCOLOURATION 28 0.0071
35 GENITOURINARY TRACT INFECTION 2 0.0071
36 FINGERPRINT LOSS 1 0.0062
37 APPLICATION SITE WOUND 1 0.0061
38 TUMOUR FLARE 4 0.0059
39 EYELASH CHANGES 1 0.0056
40 AGEUSIA 140 0.0056
41 MEDICAL DIET 1 0.0051
42 PNEUMONIA ADENOVIRAL 1 0.0051
43 PLASMA CELL LEUKAEMIA 3 0.0050
44 T-CELL TYPE ACUTE LEUKAEMIA 1 0.0049
45 STOMATITIS NECROTISING 1 0.0049
46 RED BLOOD CELL TRANSFUSION 2 0.0049
47 SALMONELLA BACTERAEMIA 1 0.0048
48 LIGHT CHAIN ANALYSIS ABNORMAL 1 0.0048
49 PYELITIS 1 0.0048
50 NAIL GROWTH ABNORMAL 5 0.0045
51 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
52 NAIL AVULSION 1 0.0044
53 ORAL CONTUSION 1 0.0043
54 HYPOGAMMAGLOBULINAEMIA 28 0.0043
55 PALATAL SWELLING 1 0.0041
56 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
57 ONYCHOCLASIS 28 0.0041
58 DYSCALCULIA 1 0.0040
59 TASTE DISORDER 82 0.0040
60 HYPOHIDROSIS 2 0.0040
61 MONOCLONAL IMMUNOGLOBULIN PRESENT 3 0.0039
62 CHEST WALL HAEMATOMA 1 0.0039
63 LIGHT CHAIN ANALYSIS INCREASED 4 0.0039
64 HERPES ZOSTER REACTIVATION 1 0.0038
65 XERODERMA 1 0.0037
66 SKIN TOXICITY 21 0.0037
67 EPIGLOTTITIS 2 0.0037
68 PRODUCT NAME CONFUSION 4 0.0037
69 IMMUNOGLOBULINS DECREASED 5 0.0036
70 VARICOSE ULCERATION 1 0.0036
71 LYMPHOCYTE ADOPTIVE THERAPY 1 0.0036
72 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
73 PSEUDOMONAL BACTERAEMIA 3 0.0035
74 HYPERVISCOSITY SYNDROME 1 0.0035
75 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
76 SALIVA ALTERED 3 0.0033
77 SALIVA DISCOLOURATION 1 0.0030
78 GIARDIASIS 1 0.0029
79 PRODUCT DOSE CONFUSION 1 0.0028
80 NONINFECTIVE ENCEPHALITIS 2 0.0028
81 TUMOUR PSEUDOPROGRESSION 3 0.0027
82 PRODUCT SELECTION ERROR 3 0.0027
83 HERPES SIMPLEX REACTIVATION 1 0.0026
84 T-CELL LYMPHOMA 3 0.0026
85 CYSTITIS VIRAL 1 0.0026
86 SPINAL CORD HAEMORRHAGE 1 0.0025
87 PARVOVIRUS INFECTION 1 0.0025
88 TONGUE ERYTHEMA 2 0.0024
89 SWEAT GLAND DISORDER 1 0.0024
90 NAIL BED DISORDER 1 0.0023
91 SKIN LAXITY 1 0.0023
92 BILIARY SEPSIS 1 0.0022
93 PLICATED TONGUE 1 0.0021
94 ATAXIA 24 0.0020
95 CORNEAL SCAR 1 0.0020
96 SALIVARY GLAND ENLARGEMENT 1 0.0019
97 ENZYME ABNORMALITY 1 0.0019
98 INTERLEUKIN LEVEL INCREASED 1 0.0018
99 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
100 BURN ORAL CAVITY 1 0.0017
101 PALMAR ERYTHEMA 2 0.0017
102 DOSE CALCULATION ERROR 1 0.0017
103 DYSGEUSIA 124 0.0017
104 DYSMETRIA 1 0.0017
105 PLEURAL DISORDER 1 0.0016
106 LIP DISCOLOURATION 2 0.0016
107 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
108 OEDEMA GENITAL 1 0.0016
109 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
110 FASCIITIS 1 0.0015
111 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
112 SKIN EXFOLIATION 126 0.0015
113 INFLAMMATORY PAIN 1 0.0015
114 B-LYMPHOCYTE COUNT DECREASED 2 0.0015
115 HAND DERMATITIS 1 0.0014
116 CRANIAL NERVE DISORDER 1 0.0014
117 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
118 SCEDOSPORIUM INFECTION 1 0.0014
119 VASOGENIC CEREBRAL OEDEMA 1 0.0014
120 SKIN ATROPHY 8 0.0014
121 PALMOPLANTAR KERATODERMA 1 0.0014
122 PLASMA CELL MYELOMA 53 0.0014
123 DANDRUFF 3 0.0014
124 BRAIN STEM SYNDROME 1 0.0013
125 LIMB ASYMMETRY 1 0.0013
126 DRY MOUTH 105 0.0013
127 METAPNEUMOVIRUS INFECTION 1 0.0013
128 LABORATORY TEST INTERFERENCE 1 0.0013
129 SUPERINFECTION BACTERIAL 1 0.0013
130 PNEUMONIA MYCOPLASMAL 1 0.0013
131 JC VIRUS INFECTION 2 0.0013
132 HERPES ZOSTER DISSEMINATED 1 0.0012
133 PRODUCT PACKAGING CONFUSION 3 0.0012
134 ORAL DISORDER 9 0.0012
135 ANAL ULCER 1 0.0012
136 CYTOPENIA 15 0.0012
137 GIANT CELL ARTERITIS 1 0.0012
138 STEM CELL TRANSPLANT 3 0.0012
139 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
140 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
141 ENTEROVIRUS INFECTION 1 0.0012
142 PRODUCT PRESCRIBING ERROR 27 0.0011
143 PARVOVIRUS B19 INFECTION 1 0.0011
144 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
145 SKIN DISORDER 37 0.0011
146 SENSITIVE SKIN 8 0.0011
147 OTOTOXICITY 2 0.0011
148 PLASMACYTOMA 2 0.0011
149 CHRONIC SINUSITIS 4 0.0011
150 INTRACRANIAL MASS 1 0.0011
151 CEREBELLAR ATAXIA 1 0.0010
152 APPLICATION SITE BRUISE 1 0.0010
153 HAEMOPHILUS INFECTION 1 0.0010
154 HYPERAEMIA 2 0.0010
155 HYPOFIBRINOGENAEMIA 1 0.0010
156 NEUROTOXICITY 17 0.0010
157 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
158 METASTASES TO PLEURA 1 0.0010
159 ORCHITIS 1 0.0009
160 TOXOPLASMOSIS 1 0.0009
161 LANGUAGE DISORDER 2 0.0009
162 PLASMA CELL MYELOMA RECURRENT 3 0.0009
163 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
164 SOFT TISSUE DISORDER 1 0.0009
165 SPINAL COLUMN INJURY 2 0.0009
166 DYSLEXIA 1 0.0009
167 DISCOURAGEMENT 2 0.0009
168 JC POLYOMAVIRUS TEST POSITIVE 1 0.0009
169 ACUTE LUNG INJURY 1 0.0008
170 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
171 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
172 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
173 PHYSICAL DECONDITIONING 2 0.0008
174 PLATELET TRANSFUSION 1 0.0008
175 CALCIUM DEFICIENCY 1 0.0008
176 COMPRESSION FRACTURE 4 0.0007
177 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
178 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
179 H1N1 INFLUENZA 1 0.0007
180 OXYGEN SATURATION ABNORMAL 2 0.0007
181 SALIVARY HYPERSECRETION 7 0.0007
182 NAIL INFECTION 1 0.0007
183 POST HERPETIC NEURALGIA 1 0.0007
184 INVESTIGATION ABNORMAL 1 0.0007
185 SEBORRHOEIC KERATOSIS 1 0.0007
186 ONYCHOMYCOSIS 3 0.0007
187 TUMOUR LYSIS SYNDROME 6 0.0007
188 CARDIAC FIBRILLATION 1 0.0007
189 PNEUMONIA PNEUMOCOCCAL 1 0.0007
190 SKIN STRIAE 1 0.0007
191 SUPERINFECTION 1 0.0007
192 HYPOSMIA 1 0.0007
193 INFECTIOUS PLEURAL EFFUSION 1 0.0007
194 MASTICATION DISORDER 2 0.0007
195 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
196 SINUS ARREST 1 0.0006
197 IRIDOCYCLITIS 2 0.0006
198 INTESTINAL ULCER 1 0.0006
199 PNEUMONIA VIRAL 2 0.0006
200 SCLERITIS 1 0.0006
201 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
202 INJECTION RELATED REACTION 1 0.0006
203 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
204 ENTEROBACTER INFECTION 1 0.0006
205 SALMONELLOSIS 1 0.0006
206 FOOD AVERSION 1 0.0006
207 SLEEP TALKING 1 0.0006
208 MUCOSAL INFLAMMATION 15 0.0006
209 SERUM FERRITIN INCREASED 3 0.0006
210 GLOSSITIS 2 0.0006
211 BONE LESION 2 0.0006
212 VULVOVAGINAL SWELLING 1 0.0005
213 SOFT TISSUE INFECTION 1 0.0005
214 DISORGANISED SPEECH 1 0.0005
215 DIFFUSE ALOPECIA 1 0.0005
216 INJECTION SITE CELLULITIS 1 0.0005
217 DYSPHAGIA 51 0.0005
218 LIP DISORDER 1 0.0005
219 HEPATIC MASS 1 0.0005
220 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
221 RHINOVIRUS INFECTION 2 0.0005
222 ORAL INFECTION 2 0.0005
223 HYPOGEUSIA 1 0.0005
224 DIPLEGIA 1 0.0005
225 EMPYEMA 1 0.0005
226 MUCOSAL DRYNESS 1 0.0005
227 SUDDEN HEARING LOSS 1 0.0005
228 DRY THROAT 5 0.0005
229 DRY SKIN 65 0.0005
230 POLYCYTHAEMIA 1 0.0005
231 CAPILLARY LEAK SYNDROME 1 0.0005
232 ANOSMIA 7 0.0005
233 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
234 HYPERPYREXIA 2 0.0005
235 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
236 TONGUE DISCOMFORT 2 0.0005
237 PRODUCT PREPARATION ISSUE 3 0.0005
238 PARONYCHIA 2 0.0005
239 RETROPERITONEAL HAEMATOMA 1 0.0005
240 BACTERIAL TEST POSITIVE 1 0.0004
241 FEEDING DISORDER 9 0.0004
242 BLOOD LOSS ANAEMIA 1 0.0004
243 METASTASES TO MENINGES 1 0.0004
244 WEIGHT DECREASED 121 0.0004
245 NEUROLOGICAL DECOMPENSATION 1 0.0004
246 MADAROSIS 5 0.0004
247 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
248 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1 0.0004
249 ESCHERICHIA BACTERAEMIA 1 0.0004
250 INGROWING NAIL 1 0.0004
251 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 74 0.0004
252 SKIN FISSURES 8 0.0004
253 HAEMATOLOGICAL INFECTION 1 0.0004
254 GLOMERULONEPHRITIS 1 0.0004
255 ACUTE PSYCHOSIS 1 0.0004
256 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
257 METASTASES TO PERITONEUM 1 0.0004
258 LABYRINTHITIS 1 0.0004
259 CANCER PAIN 1 0.0004
260 NOCARDIOSIS 1 0.0004
261 MUCORMYCOSIS 1 0.0004
262 EXFOLIATIVE RASH 1 0.0004
263 NYSTAGMUS 2 0.0004
264 EATING DISORDER 8 0.0004
265 BLOOD POTASSIUM ABNORMAL 1 0.0004
266 SENSORY LOSS 3 0.0004
267 BRADYPNOEA 1 0.0004
268 BEHAVIOUR DISORDER 2 0.0004
269 SKIN WRINKLING 1 0.0004
270 PRODUCT PRESCRIBING ISSUE 8 0.0004
271 SUBDURAL HAEMORRHAGE 1 0.0004
272 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
273 CYTOMEGALOVIRUS INFECTION 6 0.0004
274 ENDOTRACHEAL INTUBATION 1 0.0004
275 OESOPHAGEAL STENOSIS 1 0.0004
276 INJECTION SITE SCAR 1 0.0004
277 PNEUMATOSIS INTESTINALIS 1 0.0004
278 PHARYNGEAL DISORDER 1 0.0003
279 STOMATITIS 21 0.0003
280 ADENOVIRUS INFECTION 1 0.0003
281 HAEMOTHORAX 1 0.0003
282 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
283 PRODUCT LABEL CONFUSION 2 0.0003
284 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
285 BRAIN HERNIATION 1 0.0003
286 HEPATITIS B 2 0.0003
287 PLATELET COUNT ABNORMAL 2 0.0003
288 EMBOLISM VENOUS 1 0.0003
289 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
290 PENILE PAIN 1 0.0003
291 INJECTION SITE HYPERSENSITIVITY 1 0.0003
292 SWELLING OF EYELID 2 0.0003
293 HAEMATOTOXICITY 3 0.0003
294 ORAL PAIN 7 0.0003
295 HERPES SIMPLEX 2 0.0003
296 RESPIRATORY TRACT INFECTION 8 0.0003
297 PLATELET COUNT INCREASED 4 0.0003
298 ASPERGILLUS INFECTION 2 0.0003
299 DYSGRAPHIA 2 0.0003
300 ADVERSE REACTION 4 0.0003
301 SKIN INJURY 1 0.0003
302 ANXIETY DISORDER 1 0.0003
303 FULL BLOOD COUNT DECREASED 6 0.0003
304 WRONG PRODUCT ADMINISTERED 2 0.0003
305 TONGUE ULCERATION 1 0.0003
306 UVEITIS 4 0.0003
307 HEPATIC FIBROSIS 1 0.0003
308 HYPERBILIRUBINAEMIA 3 0.0003
309 DROOLING 2 0.0003
310 HAIR GROWTH ABNORMAL 2 0.0003
311 GRANULOMA 1 0.0003
312 APHONIA 4 0.0003
313 SKIN REACTION 4 0.0003
314 NEUROPATHY PERIPHERAL 27 0.0003
315 INFECTION 41 0.0003
316 ASTHMATIC CRISIS 1 0.0003
317 FOOD INTOLERANCE 1 0.0003
318 SEBORRHOEA 1 0.0003
319 AMYLASE INCREASED 1 0.0003
320 PYREXIA 93 0.0003
321 MALNUTRITION 3 0.0003
322 HYPOAESTHESIA ORAL 4 0.0003
323 PAROSMIA 2 0.0003
324 PRODUCT STORAGE ISSUE 1 0.0003
325 FACE INJURY 1 0.0003
326 GASTRIC HAEMORRHAGE 3 0.0003
327 GINGIVAL DISORDER 1 0.0003
328 FAECES HARD 1 0.0003
329 CHOKING 5 0.0003
330 BONE PAIN 15 0.0003
331 PULMONARY HAEMORRHAGE 2 0.0003
332 PROSTATOMEGALY 1 0.0003
333 MENTAL STATUS CHANGES 7 0.0003
334 SKIN PAPILLOMA 1 0.0002
335 SHOCK HAEMORRHAGIC 2 0.0002
336 HYPERURICAEMIA 1 0.0002
337 HYPERCALCAEMIA 3 0.0002
338 SPINAL STENOSIS 1 0.0002
339 GASTROINTESTINAL PERFORATION 1 0.0002
340 HAEMODIALYSIS 2 0.0002
341 HYPOPHAGIA 6 0.0002
342 ALOPECIA 46 0.0002
343 PSEUDOMONAS INFECTION 2 0.0002
344 LIVER FUNCTION TEST INCREASED 5 0.0002
345 ABNORMAL SENSATION IN EYE 1 0.0002
346 METASTATIC NEOPLASM 1 0.0002
347 HORDEOLUM 1 0.0002
348 MONOPLEGIA 1 0.0002
349 BONE CANCER 1 0.0002
350 BLOOD CALCIUM INCREASED 2 0.0002
351 LIGAMENT RUPTURE 1 0.0002
352 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
353 NERVOUS SYSTEM DISORDER 7 0.0002
354 SWOLLEN TONGUE 7 0.0002
355 GASTROINTESTINAL INFECTION 2 0.0002
356 URINARY TRACT DISORDER 1 0.0002
357 SUSPECTED OFF LABEL USE 1 0.0002
358 LIP DRY 2 0.0002
359 C-REACTIVE PROTEIN INCREASED 8 0.0002
360 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
361 ACUTE HEPATIC FAILURE 3 0.0002
362 HAEMOGLOBIN INCREASED 1 0.0002
363 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
364 RETINAL DETACHMENT 2 0.0002
365 ORAL DISCOMFORT 3 0.0002
366 INTERCEPTED MEDICATION ERROR 1 0.0002
367 RENAL FUNCTION TEST ABNORMAL 1 0.0002
368 DECREASED APPETITE 50 0.0002
369 PANCYTOPENIA 12 0.0002
370 BACTERIAL INFECTION 4 0.0002
371 PERFORMANCE STATUS DECREASED 1 0.0002
372 SKIN TIGHTNESS 1 0.0002
373 LYMPHOPENIA 3 0.0002
374 SKIN ABRASION 1 0.0002
375 SUBDURAL HAEMATOMA 3 0.0002
376 MYELODYSPLASTIC SYNDROME 3 0.0002
377 ENTEROCOCCAL INFECTION 1 0.0002
378 RASH VESICULAR 1 0.0002
379 GUILLAIN-BARRE SYNDROME 1 0.0002
380 PARKINSONISM 2 0.0002
381 HYPERVOLAEMIA 1 0.0002
382 ORGANISING PNEUMONIA 1 0.0002
383 INFLAMMATORY MARKER INCREASED 1 0.0002
384 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
385 ERYSIPELAS 1 0.0002
386 HYPOTHERMIA 2 0.0002
387 PATHOLOGICAL FRACTURE 1 0.0002
388 ENDOCARDITIS 1 0.0002
389 PRODUCT PREPARATION ERROR 4 0.0002
390 MUSCULOSKELETAL CHEST PAIN 3 0.0002
391 TEMPERATURE INTOLERANCE 2 0.0002
392 TRISMUS 1 0.0002
393 WEIGHT FLUCTUATION 2 0.0002
394 DERMATITIS 4 0.0002
395 MOUTH ULCERATION 4 0.0002
396 ADVERSE DRUG REACTION 17 0.0002
397 FULL BLOOD COUNT ABNORMAL 2 0.0002
398 CHEILITIS 1 0.0002
399 ERYTHEMA OF EYELID 1 0.0002
400 NEUTROPENIA 25 0.0002
401 SEPTIC SHOCK 8 0.0002
402 JAW DISORDER 1 0.0002
403 SKIN LESION 5 0.0002
404 NONSPECIFIC REACTION 1 0.0002
405 CHOKING SENSATION 1 0.0002
406 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
407 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
408 CARDIAC VALVE DISEASE 1 0.0002
409 NEUROLOGICAL SYMPTOM 1 0.0002
410 MOUTH SWELLING 1 0.0002
411 BLOOD URIC ACID INCREASED 1 0.0002
412 ELECTROLYTE IMBALANCE 2 0.0002
413 STRESS CARDIOMYOPATHY 1 0.0002
414 NEUTROPHIL COUNT DECREASED 7 0.0002
415 HYPOVOLAEMIA 1 0.0002
416 SPINAL PAIN 2 0.0002
417 PLATELET COUNT DECREASED 18 0.0002
418 ODYNOPHAGIA 1 0.0002
419 NOCTURIA 2 0.0002
420 ENCEPHALOPATHY 4 0.0002
421 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
422 CONJUNCTIVITIS 3 0.0002
423 HAIR COLOUR CHANGES 2 0.0002
424 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
425 SECRETION DISCHARGE 2 0.0002
426 NASAL DRYNESS 1 0.0002
427 MUSCLE ATROPHY 2 0.0002
428 HOSPITALISATION 24 0.0002
429 RASH 68 0.0002
430 INCOHERENT 1 0.0002
431 NODULE 2 0.0002
432 DEAFNESS 4 0.0002
433 SOMNAMBULISM 1 0.0002
434 IMMUNE SYSTEM DISORDER 2 0.0002
435 APPETITE DISORDER 1 0.0002
436 LIP SWELLING 5 0.0001
437 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
438 METASTASES TO LYMPH NODES 1 0.0001
439 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
440 PRODUCT LABEL ISSUE 1 0.0001
441 HYPERTRANSAMINASAEMIA 1 0.0001
442 THROMBOCYTOPENIA 16 0.0001
443 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
444 PAIN IN JAW 4 0.0001
445 ADVERSE EVENT 13 0.0001
446 DIALYSIS 2 0.0001
447 PRODUCT SUPPLY ISSUE 1 0.0001
448 IMPAIRED QUALITY OF LIFE 2 0.0001
449 PARAESTHESIA ORAL 2 0.0001
450 AMNESIA 9 0.0001
451 TONGUE DISORDER 1 0.0001
452 APATHY 2 0.0001
453 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
454 DISEASE PROGRESSION 16 0.0001
455 CEREBRAL DISORDER 1 0.0001
456 SKIN HAEMORRHAGE 2 0.0001
457 TRANSAMINASES INCREASED 3 0.0001
458 RASH MACULO-PAPULAR 3 0.0001
459 IMMUNODEFICIENCY 2 0.0001
460 SPEECH DISORDER 7 0.0001
461 ACIDOSIS 1 0.0001
462 INJECTION SITE REACTION 9 0.0001
463 HIP ARTHROPLASTY 2 0.0001
464 DEVICE RELATED INFECTION 2 0.0001
465 ATRIOVENTRICULAR BLOCK 1 0.0001
466 RASH PRURITIC 7 0.0001
467 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
468 APHTHOUS ULCER 1 0.0001
469 HAEMORRHAGIC STROKE 1 0.0001
470 MULTIPLE ALLERGIES 1 0.0001
471 DISORIENTATION 5 0.0001
472 HALLUCINATION, AUDITORY 2 0.0001
473 ATRIAL FLUTTER 1 0.0001
474 RHINITIS 1 0.0001
475 HICCUPS 1 0.0001
476 HYPERAESTHESIA 1 0.0001
477 HAIR DISORDER 1 0.0001
478 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
479 ACUTE CORONARY SYNDROME 1 0.0001
480 ANAEMIA 23 0.0001
481 EMBOLISM 1 0.0001
482 DRY EYE 6 0.0001
483 COAGULOPATHY 2 0.0001
484 OROPHARYNGEAL PAIN 11 0.0001
485 SKIN PLAQUE 1 0.0001
486 FACIAL PARALYSIS 1 0.0001
487 HEPATITIS 3 0.0001
488 ERECTILE DYSFUNCTION 3 0.0001
489 ANURIA 1 0.0001
490 BALANCE DISORDER 10 0.0001
491 MUSCLE STRAIN 1 0.0001
492 DIPLOPIA 3 0.0001
493 COLD SWEAT 2 0.0001
494 IMMUNOSUPPRESSION 1 0.0001
495 PURPURA 1 0.0001
496 CARDIOTOXICITY 1 0.0001
497 FACIAL PAIN 1 0.0001
498 MYOSITIS 1 0.0001
499 MYELOSUPPRESSION 4 0.0001
500 OROPHARYNGEAL DISCOMFORT 1 0.0001
501 BRAIN NEOPLASM 1 0.0001
502 OVARIAN CANCER 1 0.0001
503 UROSEPSIS 1 0.0001
504 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
505 FEELING COLD 3 0.0001
506 INFLUENZA 12 0.0001
507 DEMENTIA 3 0.0001
508 HEPATIC ENCEPHALOPATHY 1 0.0001
509 DYSARTHRIA 4 0.0001
510 LEUKAEMIA 1 0.0001
511 SPINAL DISORDER 1 0.0001
512 PRODUCT PACKAGING ISSUE 1 0.0001
513 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
514 ACUTE RESPIRATORY FAILURE 2 0.0001
515 ORAL HERPES 2 0.0001
516 ASCITES 3 0.0001
517 OFF LABEL USE 89 0.0001
518 HOSPICE CARE 1 0.0001
519 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
520 HYPOTONIA 1 0.0001
521 SPINAL FRACTURE 2 0.0001
522 BLOOD POTASSIUM DECREASED 3 0.0001
523 BRAIN INJURY 1 0.0001
524 HYPOTENSION 20 0.0001
525 APHASIA 3 0.0001
526 PNEUMONIA 32 0.0001
527 VERTIGO 6 0.0001
528 EPILEPSY 3 0.0001
529 MOTOR DYSFUNCTION 1 0.0001
530 EYE DISCHARGE 1 0.0001
531 TENDERNESS 1 0.0001
532 TRANSFUSION 1 0.0001
533 PARAESTHESIA 15 0.0001
534 INCONTINENCE 1 0.0001
535 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
536 HYPOAESTHESIA 14 0.0001
537 SKIN CANCER 2 0.0001
538 PRODUCT DISPENSING ERROR 2 0.0001
539 APPLICATION SITE PAIN 2 0.0001
540 BLOOD PRESSURE DECREASED 6 0.0001
541 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
542 VENTRICULAR FIBRILLATION 1 0.0001
543 TOOTH DISORDER 2 0.0001
544 GLOSSODYNIA 2 0.0001
545 THROAT IRRITATION 4 0.0001
546 SKIN INFECTION 1 0.0001
547 INTESTINAL PERFORATION 1 0.0001
548 BLISTER 5 0.0001
549 BLOOD CALCIUM DECREASED 1 0.0001
550 HYPONATRAEMIA 5 0.0001
551 PRODUCT DOSE OMISSION ISSUE 26 0.0001
552 HAEMOGLOBIN DECREASED 9 0.0001
553 INTERNAL HAEMORRHAGE 1 0.0001
554 SKIN IRRITATION 4 0.0001
555 SKIN DISCOLOURATION 4 0.0001
556 NEOPLASM 1 0.0001
557 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
558 METASTASES TO LUNG 1 0.0001
559 POST PROCEDURAL HAEMORRHAGE 1 0.0001
560 HYPOXIA 3 0.0001
561 COVID-19 PNEUMONIA 1 0.0001
562 ARRHYTHMIA 4 0.0001
563 CHOLECYSTITIS 1 0.0001
564 RASH ERYTHEMATOUS 4 0.0001
565 MUSCLE RIGIDITY 1 0.0001
566 POLYNEUROPATHY 1 0.0001
567 BLOOD PRESSURE FLUCTUATION 2 0.0001
568 RENAL IMPAIRMENT 7 0.0001
569 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
570 SEPSIS 9 0.0001
571 PHARYNGITIS 1 0.0001
572 APPLICATION SITE IRRITATION 1 0.0001
573 PNEUMONIA ASPIRATION 2 0.0001
574 INJECTION SITE DISCOLOURATION 1 0.0001
575 PEMPHIGUS 1 0.0001
576 LEUKOPENIA 4 0.0001
577 COLITIS 3 0.0001
578 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
579 FATIGUE 61 0.0001
580 TREMOR 13 0.0001
581 CHILLS 9 0.0001
582 APPLICATION SITE ERYTHEMA 2 0.0001
583 BEDRIDDEN 1 0.0001
584 ORAL CANDIDIASIS 1 0.0001
585 TOOTH INFECTION 1 0.0001
586 SARS-COV-2 TEST POSITIVE 1 0.0001
587 PRURITUS 29 0.0001
588 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
589 EYE HAEMORRHAGE 1 0.0001
590 PAIN OF SKIN 2 0.0001
591 BLOOD BILIRUBIN INCREASED 2 0.0001
592 SINUS CONGESTION 1 0.0001
593 OEDEMA 4 0.0001
594 INFLUENZA LIKE ILLNESS 6 0.0001
595 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
596 HYPOMAGNESAEMIA 1 0.0001
597 ASTHENIA 27 0.0001
598 CARDIO-RESPIRATORY ARREST 3 0.0001
599 MASS 1 0.0001
600 BLOOD TEST ABNORMAL 1 0.0001
601 BLINDNESS UNILATERAL 1 0.0001
602 HEPATOCELLULAR INJURY 1 0.0001
603 RED BLOOD CELL COUNT DECREASED 2 0.0001
604 ACCIDENTAL UNDERDOSE 1 0.0001
605 CONFUSIONAL STATE 11 0.0001
606 RENAL FAILURE 9 0.0001
607 LABORATORY TEST ABNORMAL 2 0.0001
608 URINARY INCONTINENCE 2 0.0001
609 THERAPY NON-RESPONDER 3 0.0001
610 HEPATIC FAILURE 2 0.0001
611 TENDONITIS 1 0.0001
612 BACK PAIN 15 0.0001
613 INJECTION SITE ERYTHEMA 8 0.0001
614 EJECTION FRACTION DECREASED 1 0.0001
615 COGNITIVE DISORDER 3 0.0001
616 ACUTE MYELOID LEUKAEMIA 1 0.0001
617 BRAIN FOG 1 0.0001
618 PRODUCTIVE COUGH 3 0.0001
619 CYSTITIS 2 0.0001
620 COVID-19 11 0.0001
621 DEATH 54 0.0001
622 METABOLIC ACIDOSIS 2 0.0001
623 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
624 BACK DISORDER 1 0.0001
625 INCORRECT DOSE ADMINISTERED 14 0.0001
626 METASTASES TO BONE 1 0.0001
627 PHOTOSENSITIVITY REACTION 1 0.0001
628 FEBRILE NEUTROPENIA 4 0.0001
629 VIRAL INFECTION 2 0.0001
630 URINARY RETENTION 2 0.0001
631 GAIT INABILITY 2 0.0001
632 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
633 URINARY TRACT INFECTION 10 0.0001
634 HAEMATURIA 2 0.0001
635 INFLAMMATION 3 0.0001
636 ORTHOSTATIC HYPOTENSION 1 0.0001
637 SYRINGE ISSUE 1 0.0001
638 PRODUCT STORAGE ERROR 5 0.0001
639 PANCREATITIS 3 0.0001
640 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
641 GOUT 1 0.0001
642 MOBILITY DECREASED 4 0.0001
643 OSTEOMYELITIS 1 0.0001
644 BONE DISORDER 1 0.0001
645 TREATMENT NONCOMPLIANCE 3 0.0001
646 END STAGE RENAL DISEASE 1 0.0001
647 MEDICATION ERROR 3 0.0001
648 AGRANULOCYTOSIS 1 0.0001
649 EPISTAXIS 4 0.0001
650 OXYGEN SATURATION DECREASED 3 0.0001
651 UNEVALUABLE EVENT 4 0.0001
652 MUSCULAR WEAKNESS 6 0.0001
653 ACUTE KIDNEY INJURY 8 0.0001
654 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
655 CONTUSION 5 0.0001
656 PERIPHERAL SWELLING 8 0.0001
657 HAEMATOCRIT DECREASED 1 0.0001
658 CATARACT 3 0.0001
659 BLOOD PRESSURE ABNORMAL 1 0.0001
660 UPPER LIMB FRACTURE 1 0.0001
661 SYNCOPE 5 0.0000
662 COUGH 14 0.0000
663 CARDIAC FAILURE 4 0.0000
664 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
665 PRODUCT ADMINISTRATION ERROR 1 0.0000
666 PLEURAL EFFUSION 3 0.0000
667 DISCOMFORT 3 0.0000
668 BODY TEMPERATURE INCREASED 1 0.0000
669 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
670 RIB FRACTURE 1 0.0000
671 PERITONITIS 1 0.0000
672 TOOTH LOSS 1 0.0000
673 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
674 MALAISE 20 0.0000
675 MELAENA 1 0.0000
676 TACHYCARDIA 4 0.0000
677 HEPATOTOXICITY 1 0.0000
678 HEART RATE IRREGULAR 1 0.0000
679 APPLICATION SITE PRURITUS 1 0.0000
680 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
681 MUSCLE TWITCHING 1 0.0000
682 HYPOKALAEMIA 2 0.0000
683 OCULAR HYPERAEMIA 2 0.0000
684 MENTAL IMPAIRMENT 1 0.0000
685 RESPIRATORY FAILURE 3 0.0000
686 PRESYNCOPE 1 0.0000
687 ATRIAL FIBRILLATION 4 0.0000
688 OEDEMA PERIPHERAL 5 0.0000
689 CEREBRAL INFARCTION 1 0.0000
690 LUNG DISORDER 2 0.0000
691 BRONCHITIS 3 0.0000
692 HAEMATEMESIS 1 0.0000
693 SINUSITIS 4 0.0000
694 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
695 ILLNESS 4 0.0000
696 UNRESPONSIVE TO STIMULI 1 0.0000
697 SKIN ULCER 1 0.0000
698 HAEMATOMA 1 0.0000
699 HEADACHE 24 0.0000
700 DIZZINESS 19 0.0000
701 DEPRESSED MOOD 2 0.0000
702 BRADYCARDIA 2 0.0000
703 EAR INFECTION 1 0.0000
704 DEHYDRATION 5 0.0000
705 PAIN IN EXTREMITY 11 0.0000
706 DIARRHOEA 24 0.0000
707 JAUNDICE 1 0.0000
708 FREQUENT BOWEL MOVEMENTS 1 0.0000
709 THROAT TIGHTNESS 1 0.0000
710 LIMB INJURY 1 0.0000
711 PNEUMONITIS 1 0.0000
712 MOOD ALTERED 1 0.0000
713 GAIT DISTURBANCE 7 0.0000
714 RESPIRATORY DISTRESS 1 0.0000
715 HAEMOPTYSIS 1 0.0000
716 PAIN 22 0.0000
717 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
718 ANXIETY 10 0.0000
719 EYE IRRITATION 2 0.0000
720 SEIZURE 4 0.0000
721 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
722 LIVER FUNCTION TEST ABNORMAL 1 0.0000
723 DYSSTASIA 1 0.0000
724 DYSPHONIA 2 0.0000
725 NAUSEA 27 0.0000
726 RESPIRATORY DISORDER 1 0.0000
727 IRRITABILITY 2 0.0000
728 FALL 11 0.0000
729 INJECTION SITE RASH 1 0.0000
730 NASOPHARYNGITIS 6 0.0000
731 LIMB DISCOMFORT 1 0.0000
732 VISUAL IMPAIRMENT 4 0.0000
733 SWELLING 3 0.0000
734 VOMITING 15 0.0000
735 HEAD INJURY 1 0.0000
736 LOSS OF CONSCIOUSNESS 4 0.0000
737 RHINORRHOEA 2 0.0000
738 LACTIC ACIDOSIS 1 0.0000
739 BLOOD CREATININE INCREASED 2 0.0000
740 STAPHYLOCOCCAL INFECTION 1 0.0000
741 HEART RATE INCREASED 3 0.0000
742 EXPIRED PRODUCT ADMINISTERED 1 0.0000
743 FUNGAL INFECTION 1 0.0000
744 SOMNOLENCE 6 0.0000
745 EYE PRURITUS 1 0.0000
746 FLUSHING 3 0.0000
747 FEELING ABNORMAL 7 0.0000
748 MEMORY IMPAIRMENT 4 0.0000
749 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
750 DELIRIUM 1 0.0000
751 HYPERKALAEMIA 1 0.0000
752 INJURY 2 0.0000
753 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
754 THERAPY INTERRUPTED 2 0.0000
755 HYPERGLYCAEMIA 1 0.0000
756 DYSURIA 1 0.0000
757 INJECTION SITE MASS 1 0.0000
758 DYSPNOEA EXERTIONAL 1 0.0000
759 INJECTION SITE SWELLING 2 0.0000
760 BLINDNESS 1 0.0000
761 ERYTHEMA 5 0.0000
762 ARTHRALGIA 10 0.0000
763 URTICARIA 4 0.0000
764 ABDOMINAL DISCOMFORT 4 0.0000
765 MYALGIA 4 0.0000
766 HYPERHIDROSIS 3 0.0000
767 MENTAL DISORDER 1 0.0000
768 CONSTIPATION 5 0.0000
769 MUSCULOSKELETAL STIFFNESS 2 0.0000
770 ANGIOEDEMA 1 0.0000
771 LIVER DISORDER 1 0.0000
772 INSOMNIA 6 0.0000
773 GASTROINTESTINAL DISORDER 2 0.0000
774 DRUG INEFFECTIVE 29 0.0000
775 NEPHROLITHIASIS 1 0.0000
776 ABDOMINAL PAIN 5 0.0000
777 CARDIAC DISORDER 2 0.0000
778 BLOOD GLUCOSE DECREASED 1 0.0000
779 HYPOGLYCAEMIA 1 0.0000
780 CELLULITIS 1 0.0000
781 FLUID RETENTION 1 0.0000
782 THERAPY CESSATION 1 0.0000
783 DYSPNOEA 11 0.0000
784 HAEMORRHAGE 2 0.0000
785 MUSCULOSKELETAL PAIN 1 0.0000
786 DISTURBANCE IN ATTENTION 1 0.0000
787 HAEMATOCHEZIA 1 0.0000
788 ARTHROPATHY 1 0.0000
789 WEIGHT INCREASED 4 0.0000
790 TOXICITY TO VARIOUS AGENTS 3 0.0000
791 ASTHMA 2 0.0000
792 FLATULENCE 1 0.0000
793 LETHARGY 1 0.0000
794 FEELING HOT 1 0.0000
795 DEEP VEIN THROMBOSIS 1 0.0000
796 SWELLING FACE 1 0.0000
797 INFUSION RELATED REACTION 1 0.0000
798 NEOPLASM MALIGNANT 1 0.0000
799 INJECTION SITE PRURITUS 1 0.0000
800 HEPATIC ENZYME INCREASED 1 0.0000
801 VISION BLURRED 2 0.0000
802 HYPERTENSION 3 0.0000
803 SKIN BURNING SENSATION 1 0.0000
804 HALLUCINATION 1 0.0000
805 DEPRESSION 3 0.0000
806 INJECTION SITE BRUISING 1 0.0000
807 INJECTION SITE HAEMORRHAGE 1 0.0000
808 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
809 MUSCLE SPASMS 2 0.0000
810 CHEST PAIN 2 0.0000
811 BLOOD GLUCOSE INCREASED 2 0.0000
812 PULMONARY EMBOLISM 1 0.0000
813 DRUG INTOLERANCE 1 0.0000
814 DYSPEPSIA 1 0.0000
815 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
816 PALPITATIONS 1 0.0000
817 JOINT SWELLING 1 0.0000
818 PRODUCT QUALITY ISSUE 1 0.0000
819 CONDITION AGGRAVATED 2 0.0000
820 BLOOD PRESSURE INCREASED 1 0.0000
821 INJECTION SITE PAIN 2 0.0000
822 CEREBROVASCULAR ACCIDENT 1 0.0000
823 MYOCARDIAL INFARCTION 1 0.0000
824 HYPERSENSITIVITY 1 0.0000
825 PRODUCT USE ISSUE 1 0.0000